Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Published 17/01/2024, 13:18
Updated 17/01/2024, 14:40
© Reuters.  Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock.

DatChat shares dipped 33.1% to $2.13 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • RiskOn International, Inc. (NASDAQ: ROI) shares rose 51.3% to $0.2250 in pre-market trading.
  • Meta Materials Inc. (NASDAQ: MMAT) shares jumped 33.2% to $0.0966 in pre-market trading after surging over 20% on Tuesday.
  • LQR House Inc. (NASDAQ: LQR) gained 25.2% to $2.53 in pre-market trading after dipping 45% on Tuesday. LQR House announced an increase of its share buyback program to $5 million.
  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares climbed 19.3% to $0.1514 in pre-market trading after falling more than 9% on Tuesday.
  • Zapp Electric Vehicles Group Limited (NASDAQ: ZAPP) shares gained 15.7% to $0.2950 in pre-market trading after dipping 13% on Tuesday.
  • Solid Power, Inc. (NASDAQ: SLDP) gained 15.1% to $1.37 in pre-market trading. Solid Power deepened its partnership with SK On with three new agreements.
  • Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) surged 10.7% to $0.6599 in pre-market trading. Salarius Pharmaceuticals said that the U.S. Patent and Trademark Office has issued U.S. Patent No. 11,773,080, titled “Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same.”
  • Estrella Immunopharma, Inc. (NASDAQ: ESLA) gained 9.4% to $1.40 in pre-market trading after gaining around 4% on Tuesday.
  • Ocean Biomedical, Inc. (NASDAQ: OCEA) surged 9.3% to $0.63 in pre-market trading after dipping over 8% on Tuesday.
  • Natera, Inc. (NASDAQ: NTRA) gained 8.3% to $68.10 in pre-market trading. Natera announced that jury in US District Court for W. District of Texas ruled in patent infringement lawsuit brought by Ravgen, awarding $57 million in damages, below the $410 million sought.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Phunware, Inc. (NASDAQ: PHUN) shares fell 58.7% to $0.1735 in pre-market trading. Phunware announced pricing of $7.0 million registered direct offering priced at-the-market under Nasdaq rules.
  • Remark Holdings, Inc. (NASDAQ: MARK) shares fell 21.4% to $0.5324 in pre-market trading after jumping around 48% on Tuesday.
  • MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) shares fell 12.4% to $0.1779 in pre-market trading. MyMD Pharmaceuticals has been granted Canadian patent number 3013634 Titled "Methods Of Increasing Hair Growth and Improving Hair Appearance."
  • Elevai Labs, Inc. (NASDAQ: ELAB) fell 12.4% to $1.21 in pre-market trading. ELEVAI Labs shares fell around 19% on Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio.
  • Verb Technology Company, Inc. (NASDAQ: VERB) shares declined 10.7% to $0.1160 in pre-market trading after gaining around 3% on Tuesday.
  • Adagene Inc. (NASDAQ: ADAG) shares fell 10.3% to $3.38 in pre-market trading after the company announced interim results from masked anti-CTLA-4 SAFEbody ADG126 in combination with pembrolizumab in metastatic microsatellite-stable colorectal cancer.
  • Salem Media Group, Inc. (NASDAQ: SALM) fell 9.7% to $0.30 in pre-market trading. Salem Media, last month, announced it will voluntarily delist from the Nasdaq Global Market.
  • Rail Vision Ltd. (NASDAQ: RVSN) fell 7.7% to $1.55 in pre-market trading after gaining over 20% on Tuesday.
  • CBL International Limited (NASDAQ: BANL) fell 7.4% to $1.40 in pre-market trading after gaining around 12% on Tuesday.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.